A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
NCT00443534
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
SU011248
Sponsor
Pfizer